Literature DB >> 16213175

Vaccination equally enables both genetically susceptible and resistant mice to control infection with group A streptococci.

Jeannette Siegert1, Inka Sastalla, Gursharan Singh Chhatwal, Eva Medina.   

Abstract

There is substantial evidence that host genetic factors are important in determining susceptibility to infection with group A streptococci (GAS). Several studies have revealed that, similarly to humans, a genetic component may be important in determining susceptibility to GAS infection in mice. Thus, C3H/HeN mice are much more susceptible to streptococcal infection than BALB/c mice. We have determined here whether vaccination makes genetically susceptible mice as capable as genetically resistant mice to control GAS infection. Resistant BALB/c and susceptible C3H/HeN mice were immunized either systemically with heat-killed GAS or through the mucosal route with an M protein-based subunit vaccine, and challenged with live bacteria. Vaccination elicited in both mouse strains similar levels of bactericidal anti-GAS IgG antibodies and also antigen-specific mucosal IgA. Vaccination provided mice of both strains with an increased and equal capacity to express immunity against GAS as indicated by the reduced level of bacteria in the organs and the ability of vaccinated mice to survive infection. Protection in vaccinated mice was dependent on the presence of T cell-dependent bactericidal antibodies as shown by the ability of serum elicited in immunocompetent mice but not of serum elicited in T cell-deficient nu/nu mice to passively transfer anti-GAS immunity. In conclusion, the results presented here demonstrated that the presence of anti-GAS specific, T cell-dependent bactericidal antibodies elicited after vaccination overcomes the innate genetic susceptibility of C3H/HeN mice and makes both resistant and susceptible mice equally capable of controlling GAS infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213175     DOI: 10.1016/j.micinf.2005.06.024

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  4 in total

1.  Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.

Authors:  Ivette Caro-Aguilar; Elizabeth Ottinger; Robert W Hepler; Deborah D Nahas; Chengwei Wu; Michael F Good; Michael Batzloff; Joseph G Joyce; Jon H Heinrichs; Julie M Skinner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

2.  IgG protease Mac/IdeS is not essential for phagocyte resistance or mouse virulence of M1T1 group A Streptococcus.

Authors:  Cheryl Y M Okumura; Ericka L Anderson; Simon Döhrmann; Dan N Tran; Joshua Olson; Ulrich von Pawel-Rammingen; Victor Nizet
Journal:  MBio       Date:  2013-07-30       Impact factor: 7.867

3.  Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children.

Authors:  Rasmus Mortensen; Thomas Nørrelykke Nissen; Sine Fredslund; Ida Rosenkrands; Jan Pravsgaard Christensen; Peter Andersen; Jes Dietrich
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

4.  Mechanism of protection induced by group A Streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.